Hims & Hers Health HIMS
NYSE HIMS
$27.44 -0.46 (-1.65%)
As of: Sep 10, 2026 · 3:59 PM EDT

Hims & Hers Health (HIMS) Long-Term Investments (2019 - 2025)

Hims & Hers Health's (HIMS) quarterly Long-Term Investments came in at $351.3 million in Q4 2025, down 19.87% quarter-over-quarter from $438.3 million in Q3 2025.

Analysis

Hims & Hers Health (HIMS) Long-Term Investments (2019 - 2025) Analysis & Trends

Hims & Hers Health has disclosed Long-Term Investments across 3 years of filings, most recently posting $351.3 million for Q4 2025.

  • In Q4 2025, Long-Term Investments changed N/A year-over-year to $351.3 million; the TTM figure through Dec 2025 stood at $351.3 million (changed N/A YoY), while the FY2025 annual figure was $351.3 million, changed N/A from the prior year.
  • Long-Term Investments came in at $351.3 million for Q4 2025 at Hims & Hers Health, down from $438.3 million in the prior quarter.
  • In the past five years, Long-Term Investments ranged from a high of $438.3 million in Q3 2025 to a low of $351.3 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Investments (Qtr)
1 Hinge Health 6.99 Bn 6.60 Bn 183.95 Mn 84.74 Mn
2 Hims & Hers Health 6.38 Bn 5.54 Bn 480.80 Mn -
3 Ethos Technologies 2.47 Bn 2.30 Bn 185.54 Mn 84.54 Mn
4 Omada Health 1.28 Bn 1.06 Bn 63.79 Mn -
5 Teladoc Health 1.11 Bn 330.82 Mn 416.09 Mn -
6 Talkspace 870.58 Mn 779.48 Mn 24.80 Mn -
7 Akso Health 208.18 Mn 208.01 Mn - -
8 LifeMD 145.04 Mn 145.04 Mn - -
9 eHealth 29.43 Mn -71.61 Mn - -
10 Mangoceuticals 6.82 Mn 6.58 Mn 44,215.00 -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 351.26 Mn
Sep 30, 2025 438.34 Mn
Dec 31, 2020 204.53 Mn
Sep 30, 2020 204.48 Mn
Jun 30, 2020 204.73 Mn
Mar 31, 2020 204.69 Mn
Dec 31, 2019 203.11 Mn
Sep 30, 2019 202.14 Mn